BIOCRYST PHARMACEUTICALS, INC. Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives of $572.00 thousand for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives · last filed 2012-11-08
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on foreign currency fair value hedge derivatives for the quarter ending 2012-09-30 was $572.00K, a 2.39% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on foreign currency fair value hedge derivatives for the quarter ending 2012-06-30 was $997.00K, a 0.10% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on foreign currency fair value hedge derivatives for the quarter ending 2011-09-30 was $586.00K.
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on foreign currency fair value hedge derivatives for the quarter ending 2011-06-30 was $998.00K.
| Period end | Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives 3 month | Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives 6 month | Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives 9 month |
|---|---|---|---|
| 2012-09-30 | $572.00K 10-Q · filed 2012-11-08 | $1.57M derived: sum of 2 quarters · filed 2012-11-08 | $1.53M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $997.00K 10-Q · filed 2012-08-08 | $959.00K 10-Q · filed 2012-08-08 | |
| 2011-09-30 | $586.00K 10-Q · filed 2012-11-08 | $1.58M derived: sum of 2 quarters · filed 2012-11-08 | $2.93M 10-Q · filed 2012-11-08 |
| 2011-06-30 | $998.00K 10-Q · filed 2012-08-08 | $2.34M 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |